Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004980 · ClinicalTrials.gov registry record · Phase 2
Repetitive Transcranial Magnetic Stimulation for "Voices"
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00004980 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 50 participants.
The verdict
NCT00004980, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Determine the effect of repetitive transcranial magnetic stimulation on treatment refractory auditory hallucinations of patients with schizophrenia.
Interventions
- DEVICE repetitive transcranial magnetic stimulation (rTMS)
- DEVICE sham stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 1999-12 |
| Est. Completion | 2005-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004980
The ClinicalTrials.gov registry entry for NCT00004980 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which repetitive transcranial magnetic stimulation (rTMS) is the first listed.
NCT00004980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004980 about?
NCT00004980 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation for "Voices"". OBJECTIVES: I. Determine the effect of repetitive transcranial magnetic stimulation on treatment refractory auditory hallucinations of patients with schizophrenia.
What is the current status of trial NCT00004980?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 1999-12. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00004980?
The interventions under investigation include: repetitive transcranial magnetic stimulation (rTMS) (DEVICE), sham stimulation (DEVICE).
Who is sponsoring clinical trial NCT00004980?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.